SaveHealth reports on common rheumatoid arthritis medications, highlighting their effectiveness, side effects, and cost ...
MedPage Today on MSN
Not all drugs approved for rheumatoid arthritis are equal for pain relief
Among rheumatoid arthritis (RA) patients responding to upadacitinib (Rinvoq) or adalimumab, those receiving the former had ...
SetPoint Medical, a company dedicated to developing therapies for people living with chronic autoimmune diseases, today ...
Al-Gahtani, S. (2026) Review of Literature Investigating the Correlation between Prevalence of Risk Factors Associated with ...
Minimal disease activity (MDA) was more likely in people with psoriatic arthritis (PsA) when they initiated a disease-modifying anti-rheumatic drug (DMARD) earlier rather than later. That's according ...
It can be a real pain in the neck. Rheumatoid arthritis, or RA, is an autoimmune disease in which the body mistakenly attacks ...
Nonadherence to DMARDs in RA varies widely, with rates from 1.5% to 100% across different studies and DMARD classes. The review identified 31 unique nonadherence measures, with indirect methods like ...
Objectives Multiple discontinuations of biologic (b-) or targeted synthetic (ts-) disease-modifying antirheumatic drugs (DMARDs) may indicate difficult-to-treat disease. We aimed to assess the ...
If you live with psoriatic arthritis (PsA), you know how painful and disruptive a flare can be: Stiff, swollen joints and inflamed skin can make even simple tasks feel impossible. That’s often when ...
Methotrexate significantly lowers systolic blood pressure in newly diagnosed RA patients compared to sulfasalazine, potentially reducing cardiovascular risk. The study provides prospective comparative ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback